{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"萌喵读文献-肿瘤学","title":"今日肿瘤学最高分文献 - 2025-07-11","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/aa464fa5\"></iframe>","width":"100%","height":180,"duration":132,"description":"Hey there, lab enthusiasts! Welcome to our podcast, where we bring you cutting-edge medical research. If you're not already using our AI to read your papers, you're missing out. Boost your efficiency with the科研喵app, available at labcat.com.cn. Now, dive into our topic: A groundbreaking study has uncovered the metabolic strategies behind trastuzumab resistance in HER2-positive breast cancer. Researchers have identified key mechanisms, including metabolic reprogramming, adaptive stress response, and metabolic-signaling crosstalk, which could pave the way for new therapeutic strategies to overcome resistance to this life-saving drug. Stay tuned as we explore the implications of these metabolic hallmarks in the fight against breast cancer.","thumbnail_url":"https://img.transistorcdn.com/3WX36CzvFOrNjlF7WfWjzS4HdcMIMmzMs2bmPS-ejLU/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS83NDNm/MjQ1N2E5NjhjMzVj/NjM0ZTA3YzY2NDE2/ZmIyMi5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}